Succinylation-associated lncRNA signature to predict the prognosis of colon cancer based on integrative bioinformatics analysis

[1]  Yuting Qiu,et al.  Ferroptosis-Related Long Noncoding RNAs as Prognostic Marker for Colon Adenocarcinoma , 2022, Applied bionics and biomechanics.

[2]  R. Benjamin,et al.  Engineering of an Avidity-Optimized CD19-Specific Parallel Chimeric Antigen Receptor That Delivers Dual CD28 and 4-1BB Co-Stimulation , 2022, Frontiers in Immunology.

[3]  Kecheng Zhang,et al.  Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer , 2022, Journal of Ovarian Research.

[4]  Yiping Wei,et al.  Mutations in the TTN Gene are a Prognostic Factor for Patients with Lung Squamous Cell Carcinomas , 2022, International journal of general medicine.

[5]  Da Wu,et al.  Exosomal lncRNA FOXD3-AS1 upregulates ELAVL1 expression and activates PI3K/Akt pathway to enhance lung cancer cell proliferation, invasion, and 5-fluorouracil resistance. , 2021, Acta biochimica et biophysica Sinica.

[6]  Lin Li,et al.  AC010973.2 promotes cell proliferation and is one of six stemness-related genes that predict overall survival of renal clear cell carcinoma , 2021, Scientific Reports.

[7]  Xiaohan Ren,et al.  Multi‐omics analysis reveals the interaction between the complement system and the coagulation cascade in the development of endometriosis , 2021, Scientific Reports.

[8]  Fanqiang Meng,et al.  Identification of novel autophagy-related lncRNAs associated with a poor prognosis of colon adenocarcinoma through bioinformatics analysis , 2021, Scientific Reports.

[9]  C. Qin,et al.  Integrated Analysis of the Prognosis-Associated RNA-Binding Protein Genes and Candidate Drugs in Renal Papillary Cell Carcinoma , 2021, Frontiers in Genetics.

[10]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[11]  Ling Lin,et al.  DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications , 2020, Aging.

[12]  Zhenlian Wang,et al.  FOXD3-AS1 suppresses the progression of non-small cell lung cancer by regulating miR-150/SRCIN1axis. , 2020, Cancer biomarkers : section A of Disease markers.

[13]  Xin-lin Chen,et al.  Development of Prognostic Indicator Based on Autophagy-Related lncRNA Analysis in Colon Adenocarcinoma , 2020, BioMed research international.

[14]  S. Uddin,et al.  Dysregulated Phosphorylation of p53, Autophagy and Stemness Attributes the Mutant p53 Harboring Colon Cancer Cells Impaired Sensitivity to Oxaliplatin , 2020, Frontiers in Oncology.

[15]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[16]  B. Zhang,et al.  m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer , 2020, Molecular Cancer.

[17]  Jeremy T. Moreau,et al.  Individual-patient prediction of meningioma malignancy and survival using the Surveillance, Epidemiology, and End Results database , 2020, npj Digital Medicine.

[18]  Y. Tong,et al.  KAT2A succinyltransferase activity-mediated 14-3-3ζ upregulation promotes β-catenin stabilization-dependent glycolysis and proliferation of pancreatic carcinoma cells. , 2020, Cancer letters.

[19]  Yugang Wang,et al.  Long noncoding RNA FOXD3‐AS1 promotes colon adenocarcinoma progression and functions as a competing endogenous RNA to regulate SIRT1 by sponging miR‐135a‐5p , 2019, Journal of cellular physiology.

[20]  B. Ren,et al.  Metabolic regulation of gene expression by histone lactylation , 2019, Nature.

[21]  Zhaozhi Li,et al.  Integral analyses of survival-related long non-coding RNA MIR210HG and its prognostic role in colon cancer , 2019, Oncology letters.

[22]  Hong Shen,et al.  Aggregate analysis based on TCGA: TTN missense mutation correlates with favorable prognosis in lung squamous cell carcinoma , 2019, Journal of Cancer Research and Clinical Oncology.

[23]  M. Oshima,et al.  Mutant p53 in colon cancer , 2018, Journal of molecular cell biology.

[24]  Yue Xu,et al.  CPT1A‐mediated succinylation of S100A10 increases human gastric cancer invasion , 2018, Journal of cellular and molecular medicine.

[25]  F. Boakye-Agyeman,et al.  Carnitine Palmitoyltransferase 1A Has a Lysine Succinyltransferase Activity , 2018, Cell reports.

[26]  R. McCarthy,et al.  LncPRESS1 Is a p53-Regulated LncRNA that Safeguards Pluripotency by Disrupting SIRT6-Mediated De-acetylation of Histone H3K56. , 2016, Molecular cell.

[27]  Ahmedin Jemal,et al.  Global patterns and trends in colorectal cancer incidence and mortality , 2016, Gut.

[28]  B. Schroen,et al.  Long noncoding RNAs in cardiac development and ageing , 2015, Nature Reviews Cardiology.

[29]  Hans Clevers,et al.  Sequential cancer mutations in cultured human intestinal stem cells , 2015, Nature.

[30]  H. Yao,et al.  A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis. , 2015, Cancer cell.

[31]  Sridhar Ramaswamy,et al.  Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..

[32]  Takuji Tanaka,et al.  Enhanced colitis‐associated colon carcinogenesis in a novel Apc mutant rat , 2009, Cancer science.

[33]  Zhihong Zhang,et al.  Identification and verification of lysine propionylation and butyrylation in yeast core histones using PTMap software. , 2009, Journal of proteome research.

[34]  G. Raj,et al.  How to build and interpret a nomogram for cancer prognosis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  Yi Tang,et al.  Lysine Propionylation and Butyrylation Are Novel Post-translational Modifications in Histones*S , 2007, Molecular & Cellular Proteomics.

[36]  David Allman,et al.  Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB , 2002, Nature Biotechnology.

[37]  M. Leppert,et al.  Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps , 1998, Nature Genetics.

[38]  Lieping Chen,et al.  Amplification of tumor immunity by gene transfer of the co‐stimulatory 4‐1BB ligand: synergy with the CD28 co‐stimulatory pathway , 1998, European journal of immunology.

[39]  Lawrence N Kwong,et al.  APC and its modifiers in colon cancer. , 2009, Advances in experimental medicine and biology.

[40]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.